Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

ESCAPE Bio
4000 Shoreline Court, Suite 400
South San Francisco, CA 94080
Phone: 650-431-0100
https://www.escapebio.com/

ESCAPE Bio is a clinical stage, privately held biopharmaceutical company developing novel, precisely targeted therapeutics for genetically defined neurodegenerative diseases. ESB1609 is in a Phase 1 multiple ascending dose study in healthy volunteers. ESCAPE has advanced a mutant-selective LRRK2 G2019S kinase inhibitor for Parkinson's Disease (PD) patients to IND-enabling studies. A pharmacologic structure corrector of Alzheimer's patients carrying the ApoE4 risk allele is in Discovery.

Key Contact
Name
Julie Smith
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
09/14/20 $73,000,000 Crossover Financing Avidity Partners
CAM Capital
Johnson & Johnson Innovation
New Leaf Venture Partners
Novartis Venture Funds
Novo Holdings
OrbiMed Advisors
Osage University Partners
Rock Springs Capital
Sphera Funds Management
Surveyor Capital
Wellington Management Company